These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8282035)

  • 1. Early epithelial lesions in cataracts of GSH-depleted mouse pups.
    Laver NM; Robison WG; Calvin HI; Fu SC
    Exp Eye Res; 1993 Oct; 57(4):493-8. PubMed ID: 8282035
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.
    Mårtensson J; Steinherz R; Jain A; Meister A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8727-31. PubMed ID: 2813421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid deterioration of lens fibers in GSH-depleted mouse pups.
    Calvin HI; Medvedovsky C; David JC; Broglio TM; Hess JL; Fu SC; Worgul BV
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1916-24. PubMed ID: 2032811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lens GSH depletion and electrolyte changes preceding cataracts induced by buthionine sulfoximine in suckling mice.
    Calvin HI; von Hagen S; Hess JL; Patel SA; Fu SC
    Exp Eye Res; 1992 Apr; 54(4):621-6. PubMed ID: 1623947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice.
    Calvin HI; Medvedovsky C; Worgul BV
    Science; 1986 Aug; 233(4763):553-5. PubMed ID: 3726547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
    Maitra I; Serbinova E; Tritschler HJ; Packer L
    Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lens biochemistry and structure between BSO-treated and glucocorticoid-treated developing chick embryos.
    Murakami I; Kosano H; Ogihara-Umeda I; Nishigori H; Uga S; Ishikawa S
    Exp Eye Res; 1996 Dec; 63(6):673-81. PubMed ID: 9068374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticataractogenic property of gamma-glutamylcysteine ethyl ester in an animal model of cataract.
    Ohtsu A; Kitahara S; Fujii K
    Ophthalmic Res; 1991; 23(1):51-8. PubMed ID: 1870842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate.
    Calvin HI; Zhu G; Wu J; Banerjee U; Fu JS
    Exp Eye Res; 1997 Sep; 65(3):341-7. PubMed ID: 9299171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive modifications of mouse lens crystallins in cataracts induced by buthionine sulfoximine.
    Calvin HI; Patel SA; Zhang JP; Li MY; Fu SC
    Exp Eye Res; 1992 Apr; 54(4):611-9. PubMed ID: 1623946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
    Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
    Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from oxidative insult in glutathione depleted lens epithelial cells.
    Reddan JR; Giblin FJ; Kadry R; Leverenz VR; Pena JT; Dziedzic DC
    Exp Eye Res; 1999 Jan; 68(1):117-27. PubMed ID: 9986749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buthionine sulfoximine induced cataracts in mice contain insolubilized crystallins with calpain II cleavage sites.
    David LL; Calvin HI; Fu SC
    Exp Eye Res; 1994 Oct; 59(4):501-4. PubMed ID: 7859826
    [No Abstract]   [Full Text] [Related]  

  • 14. State of sulfhydryl in selenite cataract.
    David LL; Shearer TR
    Toxicol Appl Pharmacol; 1984 Jun; 74(1):109-15. PubMed ID: 6729815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications in lens protein biosynthesis signal the initiation of cataracts induced by buthionine sulfoximine in mice.
    Calvin HI; Wu JX; Viswanadhan K; Fu SC
    Exp Eye Res; 1996 Oct; 63(4):357-68. PubMed ID: 8944543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine supplementation protects lens against glutathione depletion.
    Sevin G; Kerry Z; Sozer N; Ozsarlak-Sozer G
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4520-4526. PubMed ID: 34286494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swelling of the lens fibers.
    Sakuragawa M; Kuwabara T; Kinoshita JH; Fukui HN
    Exp Eye Res; 1975 Oct; 21(4):381-394. PubMed ID: 1218545
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts.
    Li W; Calvin HI; David LL; Wu K; McCormack AL; Zhu GP; Fu SC
    Exp Eye Res; 2002 Sep; 75(3):335-46. PubMed ID: 12384096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine structure of lentoid bodies derived from normal and cataractous mouse lenses.
    Huang FL; Russell P; Kuwabara T
    Exp Eye Res; 1980 Nov; 31(5):535-41. PubMed ID: 6256195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.